Robin J. Shattock mostly deals with Virology, Microbicides for sexually transmitted diseases, Immunology, Microbicide and Virus. His Virology research incorporates elements of Explant culture, In vitro and Griffithsin. His work focuses on many connections between Microbicides for sexually transmitted diseases and other disciplines, such as Sexual transmission, that overlap with his field of interest in Pharmacology.
His Immunology course of study focuses on Vagina and Epithelium, Transmission and Acquired immunodeficiency syndrome. His research in Microbicide intersects with topics in Viral entry and Intensive care medicine. Robin J. Shattock regularly ties together related areas like Vaginal microbicide in his Virus studies.
Robin J. Shattock spends much of his time researching Virology, Immunology, Virus, Microbicide and Microbicides for sexually transmitted diseases. Robin J. Shattock has researched Virology in several fields, including Explant culture, In vitro and Antibody. His work in Immunology addresses subjects such as Ex vivo, which are connected to disciplines such as Pathogenesis.
The study incorporates disciplines such as Peripheral blood mononuclear cell, Dendritic cell and Microbiology in addition to Virus. His Microbicide study incorporates themes from Viral entry, Dapivirine, Vaginal microbicide and Pharmacology. Robin J. Shattock focuses mostly in the field of Microbicides for sexually transmitted diseases, narrowing it down to topics relating to Sexual transmission and, in certain cases, Sexually transmitted disease.
His primary areas of study are Virology, Immunology, Antibody, Virus and Microbicide. His biological study spans a wide range of topics, including Explant culture, Ex vivo, In vitro and Immune system. Robin J. Shattock regularly links together related areas like Intravaginal administration in his Immunology studies.
His work deals with themes such as Transmission and Peripheral blood mononuclear cell, which intersect with Virus. Robin J. Shattock has included themes like Microbicides for sexually transmitted diseases and Dapivirine in his Microbicide study. In his study, which falls under the umbrella issue of Microbicides for sexually transmitted diseases, Gp41 is strongly linked to Viral replication.
Robin J. Shattock focuses on Virology, Microbicide, Explant culture, Virus and Microbicides for sexually transmitted diseases. His Virology research is multidisciplinary, incorporating elements of Ex vivo, In vitro and Cyanovirin-N. The various areas that Robin J. Shattock examines in his Microbicide study include Dapivirine and Reverse-transcriptase inhibitor.
The Explant culture study which covers Vaginal microbicide that intersects with Interleukin 4 and Peripheral blood mononuclear cell. His Microbicides for sexually transmitted diseases study combines topics in areas such as Urethra, Penis and Pathology. His research investigates the connection between Viral entry and topics such as Intravaginal administration that intersect with problems in Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
In vitro and in vivo: the story of nonoxynol 9.
Sharon L Hillier;Thomas Moench;Robin Shattock;Roberta Black.
Journal of Acquired Immune Deficiency Syndromes (2005)
Inhibiting sexual transmission of HIV-1 infection
Robin J. Shattock;John P. Moore.
Nature Reviews Microbiology (2003)
Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120
Ronald S. Veazey;Robin J. Shattock;Melissa Pope;J. Christian Kirijan.
Nature Medicine (2003)
Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides.
Peter Greenhead;Peter Hayes;Patricia S. Watts;Ken G. Laing.
Journal of Virology (2000)
Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.
Ronald S. Veazey;Per Johan Klasse;Susan M. Schader;Qinxue Hu.
Nature (2005)
Target cells in vaginal HIV transmission.
Christopher J. Miller;Robin J. Shattock.
Microbes and Infection (2003)
Cyanovirin-N Inhibits AIDS Virus Infections in Vaginal Transmission Models
Che Chung Tsai;Peter Emau;Yonghou Jiang;Michael B. Agy.
AIDS Research and Human Retroviruses (2004)
Selective transmission of CCR5-utilizing HIV-1: the 'gatekeeper' problem resolved?
Leonid Margolis;Robin Shattock.
Nature Reviews Microbiology (2006)
Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component
Barry R. O'Keefe;Fakhrieh Vojdani;Viviana Buffa;Robin J. Shattock.
Proceedings of the National Academy of Sciences of the United States of America (2009)
Mycobacterial 65-kD heat shock protein induces release of proinflammatory cytokines from human monocytic cells.
J. S. Friedland;R. Shattock;D. G. Remick;G. E. Griffin.
Clinical and Experimental Immunology (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
St George's, University of London
St George's, University of London
Cornell University
National Institutes of Health
University of New South Wales
Cornell University
Sidra Medicine
Northwestern University
Duke University
Duke University
University of Chicago
Federal Reserve Bank of San Francisco
Google (United States)
University of Glasgow
Jilin University
East China Normal University
MIT
Norwegian University of Life Sciences
RWTH Aachen University
University of Queensland
University of Münster
University of Washington
Wageningen University & Research
University of California, Los Angeles
Uppsala University
Argonne National Laboratory